Optina Diagnostics Inc.

Our revolutionary approach combines state-of the art eye imagery and artificial intelligence to help healthcare professionals improve disease detection. Our first test for Cerebral Amyloid Status, identifies an important risk factor for Alzheimer’s disease. With this test, Optina aims to shape the future and change mindsets when it comes to Brain Health, by providing easily accessible and meaningf

ul information for physicians evaluating patients with cognitive decline. We all know someone suffering from memory loss, and the uncertainties and worries it provokes for them and their loved ones. With the current diagnostic tools, it is difficult to evaluate the exact clinical condition, even for experts in dementia. At the same time, early detection allows the patient to make lifestyle changes that may delay the disease, or possibly even improve cognition. Come and join us, together we can make memory loss a souvenir. https://optinadx.com/get-involved/